Archives for October 2025

What if we could?

25 years in and decades more to go at Ontario Genomics!

This year’s annual report comes at a milestone time and the past year has been a remarkable one with exciting progress in our health, cleantech and food and agriculture projects.

As Ontario Genomics marks its 25th year, we celebrate our success in funding cutting-edge science projects that are producing homegrown solutions to some of humanity’s biggest challenges. In this 2024-25 annual report, you’ll see how we’re backing real winners in precision healthcare, biotech SMEs, food biomanufacturing, environmental testing and waste upcycling.

Looking into the future of the province’s workforce, we also ensure Ontario’s young people are informed and inspired about all the exciting opportunities biotechnology is creating, and how they can be a part of it. Now, more than ever, Ontario Genomics is focused on getting innovative research out of the lab and into the real world for everyone’s benefit.

This report features several inspiring examples of how our exceptional team nurtures ideas into reality. We hope you’re as motivated by it as we are! What if we could is more than a theme, it’s a commitment to transforming scientific discovery into practical, market-ready solutions. As Ontario Genomics enters its next 25 years, we will continue to turn this vision into impact for Ontario, Canada and the world.

Ontario Genomics’ Regional GAPP

Regional Genomic Applications Partnership Program (GAPP)

Fuelling Ontario’s Next Generation of Biotech Spinouts

Ontario Genomics is launching our Regional Genomic Applications Partnership Program (GAPP) to accelerate the commercialization of academic discoveries into made-in-Ontario biotech solutions.

Ontario is home to world-class researchers and institutions producing groundbreaking discoveries, yet many of them fail to progress beyond the lab. That’s because spinout companies (formed to commercialize academic intellectual property) that bring these innovations to market are often stifled by insufficient access to capital, long commercialization timelines and limited business expertise.

Thanks in part to a four year, $4 million commitment from Genome Canada, Ontario Genomics’ Regional GAPP is addressing these challenges by supporting spinouts at this critical lab-to-company technology transfer stage, facilitating R&D capacity, independence from academia and positioning them for seed financing. The end results will fuel job creation, company retention, IP generation and attract foreign investment, while reinforcing Ontario’s economic resilience and global reputation in genomics innovation.

Eligibility Criteria:

  • Your spinout company is incorporated in Canada and based in Ontario
  • Your spinout can commit $222,578 cash or in-kind over the two years of the program
  • Your technology is genomics or biotech enabled
  • Your spinout company is partnered with an Ontario-based researcher
  • Your company has at least two people (if the lead project researcher is also the CEO, the company’s governance board must have at least one additional member)

If you meet the above criteria, please visit the program page and fill out the intake form by Oct 24th.